GIM
EPZM

Granahan Investment Management’s Epizyme, Inc EPZM Stock Holding History

Granahan Investment Management’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,194,926
Closed -$9.93M – 207
2021
Q2 		$9.93M Buy
1,194,926
+12,854
+1% +$108K 0.19% 115
2021
Q1 		$10.3M Buy
1,182,072
+327,976
+38% +$3.39M 0.22% 91
2020
Q4 		$9.28M Buy
854,096
+452,240
+113% +$5.58M 0.21% 96
2020
Q3 		$4.79M Buy
+401,856
New +$5.38M 0.16% 110

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Granahan Investment Management's EPZM Position: Q3 2021 in Review

Granahan Investment Management sold out of Epizyme, Inc (EPZM) in Q3 2021, closing a stake of 1,194,926 shares — an estimated $9.93M sold.

Granahan Investment Management first reported a position in EPZM in Q3 2020 and held it in 4 quarters. The position peaked at $10.3M in Q1 2021. 116 funds tracked by Wall St. Rank hold EPZM as of Q3 2021.

  • Granahan Investment Management reported no remaining Epizyme, Inc position as of Q3 2021 after selling out during the quarter.
  • Granahan Investment Management sold 1,194,926 Epizyme, Inc shares in Q3 2021, an estimated $9.93M.
  • Granahan Investment Management first reported a position in Epizyme, Inc in Q3 2020 and held it in 4 quarters.
  • Granahan Investment Management's Epizyme, Inc position peaked at $10.3M in Q1 2021.
  • 116 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2021.

Based on Granahan Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.